Medline MDLN
NASDAQ MDLN
$34.42 -0.27 (-0.79%)
As of: Sep 9, 2026 · 11:24 AM EDT

Medline (MDLN) EV to EBIT (2026)

Medline's (MDLN) quarterly EV to EBIT came in at 141.6 in Q2 2026, down 0.72% quarter-over-quarter from 142.63 in Q1 2026.

Analysis

Medline (MDLN) EV to EBIT (2026) Analysis & Trends

Medline (MDLN) has reported EV to EBIT for 1 consecutive years, with 141.6 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EV to EBIT changed N/A year-over-year to 141.6 in Q2 2026; TTM through Jun 2026 was 27.55, a N/A change from a year earlier, with the FY2025 full-year figure at 27.94, changed N/A from the prior year.
  • EV to EBIT was 141.6 for Q2 2026 at Medline, down from 142.63 in the prior quarter.
  • Over five years, EV to EBIT peaked at 142.63 in Q1 2026 and troughed at 141.6 in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Becton Dickinson 49.43 Bn 48.56 Bn 2.32 Bn
2 Medline 29.49 Bn 26.81 Bn 2.22 Bn
3 West Pharmaceutical Services 23.95 Bn 23.51 Bn 329.20 Mn
4 Baxter International 12.85 Bn 10.70 Bn 1.03 Bn
5 Stevanato Group S.p.A 5.58 Bn 5.47 Bn 100.91 Mn
6 Acme United 232.75 Mn 227.71 Mn 26.69 Mn
7 Rockwell Medical 32.38 Mn 7.58 Mn 3.24 Mn
8 Retractable Technologies 20.96 Mn -18.91 Mn 190,852.00
9 United Health Products 9.09 Mn 9.06 Mn -
10 Cuprina Holdings (Cayman) 7.55 Mn 4.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 141.60
Mar 28, 2026 142.63